Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Coca-Cola annual organic revenue guidance tops estimates

Published 02/13/2024, 07:04 AM
Updated 02/13/2024, 07:40 AM
© Reuters.

Investing.com -- Coca-Cola (NYSE:KO) has said it expects to deliver full-year adjusted organic revenue growth of 6% to 7%, just ahead of Bloomberg consensus predictions of 5.9% but slower than the pace registered in 2023, signalling a waning benefit from a recent surge in prices.

The beverage behemoth, much like rival PepsiCo (NASDAQ:PEP), has lifted prices in response to elevated inflationary pressures, boosting revenues but threatening to weigh on demand from cost-conscious American shoppers. However, unlike PepsiCo, which posted a 4% dip in unit sales volumes in its most recent quarter, demand at Coca-Cola has remained somewhat resilient.   

In the three months ended on Dec. 31, unit case volume in North America slid by 1%, partly reflecting weakness in demand for the company's water, coffee, tea, and sports drinks. The downturn was offset by higher volumes in Europe and Latin America. Total unit case volumes grew by 2%, unchanged from the previous quarter.

Price mix, a measure of the value of the firm's products, jumped by 9%.

Fourth-quarter comparable earnings per share increased by 10% to $0.49, meeting Wall Street estimates. Adjusted operating revenue of $10.8 billion were just above projections of $10.65B.

Shares in Coca-Cola hovered just above the flatline in premarket U.S. trading.

Latest comments

Doesn't anyone realize the contradiction when writing this nonsense? Inflationary price increase would see earnings flat, not a 10% beat! Coke and all the others ARE inflation, not reactionary to. These type products should be taxed  obscenely, via a correlation index to health care industry profits. The sicker fat Americans get because of the use of these products, the richer both industries get.
Doesn't anyone realize the contradiction when writing this nonsense? Inflationary price increase would see earnings flat, not a 10% beat! Coke and all the others ARE inflation, not reactionary to. These type products should be taxed  obscenely, via a correlation index to health care industry profits. The sicker fat Americans get because of the use of these products, the richer both industries get.
Nazi's on the DUTY DESK this morning! Good morning NAZI. Constantly have to remind about that miserable 1st amendment right, which is the only reason you have a job!
Doesn't anyone realize the contradiction when writing this nonsense? Inflationary price increase would see earnings flat, not a 10% beat! Coke and all the others ARE inflation, not reactionary to. These type products should be taxed  obscenely, via a correlation index to health care industry profits. The sicker fat Americans get because of the use of these products, the richer both industries get.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.